Source study found

Story checked

Science thought the human lifespan was 122 years. A new model says we could live decades longer. - Upworthy (opens in a new tab)

Science thought the human lifespan was 122 years. A new model says we could live decades longer. · 2026-07-22

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One key claim is not backed by the study. One other point was not covered by the paper.

1 supported
2 overstated
1 not supported
1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Science thought the human lifespan was 122 years. A new model says we could live decades longer. - Upworthy

Science thought the human lifespan was 122 years. A new model says we could live decades longer. · 2026-07-22

The story’s checkable claims.

Read the original story

NewsLink checks it

Mostly not supported

Three claims go beyond the study. Two overstate it and one isn't supported at all. One claim the study doesn't address.

1 supported
2 overstated
1 not supported
1 not covered

Open claim evidence

The source study

Somatic mutations impose an entropic upper bound on human lifespan

Npj Aging · 2026Open access

Open source record Open in Tessa

Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

The study this story reportspresented as the new finding
Somatic mutations impose an entropic upper bound on human lifespan
Npj Aging · 2026
PubMed (opens in a new tab)Full Tessa analysis (opens in a new tab)
Cited as backgroundpresented as earlier work
https://pmc.ncbi.nlm.nih.gov/articles/PMC8636159/
Where the story links (opens in a new tab)

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not supportedThe researchers created a model that removed the effects of somatic mutations; without them, the model suggested humans could potentially live as long as 156 years.View evidenceHide evidence

As stated156 years

Why this verdict

This reverses the key counterfactual described in the paper profile. The profile says the model estimated lifespan limits when all aging hallmarks were eliminated except somatic mutations; under that somatic-mutation-only counterfactual, median lifespan was reduced to 156 years from a theoretical non-aging baseline. The story claim says the model removed the effects of somatic mutations and that 'without them' humans could potentially live 156 years, which is not what the supplied profile reports.

Study evidence

An incremental in-silico population survival modeling framework was developed and applied to estimate lifespan limits under the counterfactual that all aging hallmarks except somatic mutations are eliminated.

“We developed an incremental modeling framework that progressively incorporates factors contributing to aging into a model of population survival dynamics”

Study evidence

Multi-organ integration predicts a mutation-limited median human lifespan of approximately 146–194 years.146–194 years

“Multi-organ integration predicts median lifespans of 146-194 years-approximately twice current human longevity.”

Claim 2 of 5OverstatedA July 2026 paper published in npj Aging says humans may have the potential to live as long as 156 years.View evidenceHide evidence

As statedas long as 156 years

Why this verdict

The paper profile supports a model-derived lifespan estimate involving 156 years, but the story's lead framing that humans may have the 'potential to live as long as 156 years' compresses important conditions. In the profile, 156 years is a modeled median under a counterfactual somatic-mutation-only scenario, while the multi-organ integration predicts median lifespans of about 146–194 years. The lead therefore makes the number sound like a direct human potential or upper-limit claim rather than a conditional in-silico estimate.

Study evidence

“We developed an incremental modeling framework that progressively incorporates factors contributing to aging into a model of population survival dynamics”

Study evidence

Multi-organ integration predicts a mutation-limited median human lifespan of approximately 146–194 years.146–194 years

“Multi-organ integration predicts median lifespans of 146-194 years-approximately twice current human longevity.”

Claim 3 of 5OverstatedRussian researchers Evgeniy Efimov, Vlad Fedotov, and Leonid Malaev based their paper on analyses of human DNA and the body’s aging process and argued that somatic mutations may hold the key to a longer human lifespan.View evidenceHide evidence

Why this verdict

The profile supports that the researchers used an in-silico aging/survival model centered on somatic mutations and concluded that somatic mutations substantially contribute to aging-driven mortality. However, saying somatic mutations may 'hold the key to a longer human lifespan' overstates the paper's abstract-level inference: the profile says somatic mutations are substantial but insufficient, with other aging hallmarks contributing comparably. The author names, Russian affiliation, and any specific 'analyses of human DNA' are not independently verifiable from the supplied abstract-level profile.

Study evidence

“We developed an incremental modeling framework that progressively incorporates factors contributing to aging into a model of population survival dynamics”

Study evidence

Multi-organ integration predicts a mutation-limited median human lifespan of approximately 146–194 years.146–194 years

“Multi-organ integration predicts median lifespans of 146-194 years-approximately twice current human longevity.”

Claim 4 of 5Not coveredMany researchers have long believed the human lifespan has a natural upper limit of about 122 years, according to a 2021 study published in Oncoscience.View evidenceHide evidence

As statedabout 122 years

Why this verdict

The supplied abstract-level paper profile does not address a 2021 Oncoscience study, a historically believed 122-year natural upper limit, or researchers' prior consensus. This may be background from outside the profiled paper, but it is not verifiable from the supplied paper evidence.

Claim 5 of 5SupportedThe article says the study did not offer a way to extend the human lifespan and notes other aging processes were not ruled out, including mitochondrial dysfunction, epigenetic drift, telomere shortening, and loss of proteostasis.View evidenceHide evidence

Why this verdict

The supplied profile supports the main caveats: the work is an in-silico model rather than a demonstrated intervention, and the authors infer that somatic mutations cannot alone account for observed mortality, implying important roles for other aging hallmarks. The specific named processes listed in the story are not present in the abstract-level profile, but the broader claim that other aging processes were not ruled out is consistent with the supplied evidence.

Study evidence

“We developed an incremental modeling framework that progressively incorporates factors contributing to aging into a model of population survival dynamics”

Study evidence

Multi-organ integration predicts a mutation-limited median human lifespan of approximately 146–194 years.146–194 years

“Multi-organ integration predicts median lifespans of 146-194 years-approximately twice current human longevity.”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

The key counterfactual eliminates all aging hallmarks except somatic mutations, rather than eliminating somatic mutations.
This is an interpretation-changing point. The story claim c4 describes the model as removing somatic mutations and estimating lifespan 'without them,' whereas the paper profile says somatic mutations are the remaining aging mechanism in the counterfactual.
From in_silico incremental survival modeling / counterfactual analysis; in_silico multi-compartment/multi-organ integration
The paper reports a model-derived 156-year median lifespan under a somatic-mutation-only scenario and a multi-organ integrated median range of approximately 146–194 years.
The story mentions 156 years, but it frames the value as 'as long as' humans may live and does not clearly identify it as a modeled median under a specific counterfactual. It also omits the 146–194-year multi-organ median range, which is the broader quantitative result in the profile.
From in_silico incremental survival modeling / counterfactual analysis; in_silico multi-compartment/multi-organ integration
The paper predicts organ-specific longevity bottlenecks: post-mitotic tissues such as neurons and cardiomyocytes are limiting, while proliferating tissues such as liver are modeled as maintaining function far longer via cellular replacement.
This is a primary contribution in the paper profile, but the story presentation does not mention the organ-specific bottleneck analysis or the contrast between post-mitotic and proliferating tissues.
From in_silico organ-level modeling

2 things the story did carry across

The paper's central method is an incremental in-silico population survival modeling framework used for counterfactual lifespan estimation.
The paper concludes that somatic mutations substantially drive aging but cannot alone explain observed human mortality, implying comparable contributions from other aging hallmarks.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

in silico

1Lead resultin silicoDevelop an incremental computational modeling framework for population survival dynamics that isolates somatic mutations (with other aging hallmarks removed) to estimate an upper bound on human lifespan.in silico incremental survival modeling / counterfactual analysisExpand

In plain English

Authors developed an incremental, in-silico population survival modeling framework that progressively incorporates aging factors and is used in counterfactual analyses removing all aging hallmarks except somatic mutations to estimate upper bounds on human lifespan.

Key findings

An incremental in-silico population survival modeling framework was developed and applied to estimate lifespan limits under the counterfactual that all aging hallmarks except somatic mutations are eliminated.
The model predicts strong organ asymmetry: post-mitotic cells (neurons, cardiomyocytes) act as critical longevity bottlenecks, whereas proliferating tissues (e.g., liver) can maintain functionality for very long periods through cellular replacement.

“We developed an incremental modeling framework that progressively incorporates factors contributing to aging into a model of population survival dynamics”

2in silicoUse the model to predict organ-specific ‘longevity bottlenecks’, with post-mitotic tissues (neurons, cardiomyocytes) limiting lifespan far more than proliferating tissues (e.g., liver) due to cellular replacement.in silico organ-level modelingExpand

In plain English

Using an incremental in silico survival-modeling framework applied at organ level, the authors report a pronounced asymmetry across tissues: post-mitotic cell types (examples cited: neurons and cardiomyocytes) are predicted to act as critical longevity bottlenecks susceptible to somatic-mutation-driven decline, whereas proliferating tissues (example cited: liver) are predicted to maintain functionality for millennia via cellular replacement, effectively neutralizing mutation-driven functional loss.

Key findings

Post-mitotic tissues (examples: neurons and cardiomyocytes) are predicted by the model to act as critical longevity bottlenecks susceptible to somatic-mutation-driven functional decline.
Proliferating tissues such as liver are predicted to maintain functionality for thousands of years through cellular replacement, effectively neutralizing mutation-driven decline in those tissues.

“Our analysis reveals fundamental asymmetry across organs: post-mitotic cells such as neurons and cardiomyocytes act as critical longevity bottlenecks”

What this piece can’t prove

3 further details could not be confirmed from the summary.

3in silicoIntegrate multi-organ constraints to estimate the mutation-limited median human lifespan range (≈146–194 years) and infer that other hallmarks must contribute comparably to explain observed mortality.in silico multi-compartment/multi-organ integrationExpand

In plain English

Using an incremental in silico modeling framework that integrates organ-specific constraints into a population survival model, the authors estimate a mutation-limited median human lifespan of approximately 146–194 years and conclude that somatic mutations, while a substantial driver of aging, alone cannot account for observed human mortality, implying comparable contributions from other aging hallmarks.

Key findings

Multi-organ integration predicts a mutation-limited median human lifespan of approximately 146–194 years.146–194 years
This substantial yet incomplete reduction in predicted lifespan implies somatic mutations significantly drive aging but cannot alone account for observed human mortality; other hallmarks must contribute comparably.